TORRANCE, CA, - Phenomenex, Inc., a global leader in separation science, announces its participation at Analytica 2026, the world’s leading trade fair for laboratory technology, analysis, and biotechnology, taking place in Munich, Germany. Attendees are invited to explore Phenomenex’s latest innovations designed to address today’s most demanding analytical challenges in biologics characterization, oligonucleotide bioanalysis, and PFAS testing workflows: 

Biozen dSEC-1 size exclusion chromatography (SEC) columns, engineered for high resolution aggregate analysis of peptides and mid-sized biologics (1–50 kDa). Designed to support modern biotherapeutic development, Biozen dSEC-1 enables faster analyses, improved peak symmetry, and extended column lifetime, empowering scientists to confidently characterize aggregates, monomers, and closely related species in peptide therapeutics. 

Clarity OTX Pro, a next generation solid phase extraction (SPE) kit designed to standardize and simplify oligonucleotide and oligo conjugate extraction for LC-MS/MS bioanalysis. Purpose built for modern oligonucleotide therapeutics, Clarity OTX Pro is designed to overcome common challenges such as day-to-day variability and extensive method optimization. 

Designed for PFAS portfolio, a comprehensive suite of QC tested and PFAS verified consumables engineered to reduce background contamination and false positives in trace level PFAS analysis. As PFAS regulations continue to evolve globally, the Designed for PFAS portfolio empowers laboratories to maintain data integrity, meet compliance requirements, and streamline PFAS workflows with confidence.